Qatar’s genetic counseling landscape: Current insights and future prospects
Sumaya Abiib(Qatar University), Mashael Al‐Shafai(Qatar University), Houssein Khodjet‐El‐Khil(Qatar University), Tawfeg Ben‐Omran(Qatar Airways (Qatar)), Reem Ibrahim Bux(Hamad Medical Corporation), Reem Al Sulaiman(Hamad Medical Corporation), Karen El‐Akouri(Hamad Medical Corporation), Said I. Ismail(Qatar Foundation), Noora Shahbeck(Hamad Medical Corporation), Zoulikha Rezoug(Qatar University), Wafa Abualainin(Hamad Medical Corporation), Asma Al-Thani(Qatar University), Maria Farag, Rehab Al Saleh(Hamad Medical Corporation), Moza Khalifa Alkowari(Hamad Medical Corporation), Mariam Al Mulla(Abu Dhabi Health Services), Sara Musa(Hamad Medical Corporation)
Cited by 10
Related Papers
Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study
|Neuromuscular Disorders|2019|636
Exome Sequencing Links Corticospinal Motor Neuron Disease to Common Neurodegenerative Disorders
|Science|2014|548
Global Biobank Meta-analysis Initiative: Powering genetic discovery across human disease
|Cell Genomics|2022|422
Aptamers Chemistry: Chemical Modifications and Conjugation Strategies
|Molecules|2019|396